x

AAV Vector Discovery Platform
Ophthalmic Drug Delivery System

Our platform specializes in the discovery and development of AAV vectors for targeted gene therapy in ophthalmology.

  • AI Assisted Design

    Leveraging AI for optimized vector design and enhanced efficacy.

  • Targeted Delivery

    Precise targeting of ocular tissues for maximized therapeutic impact.

  • High-Titer Production

    Robust and scalable AAV production for efficient preclinical studies.

  • Comprehensive Analysis

    In-depth characterization and validation of vector performance.

OPHTHALMIC DRUG DELIVERY SYSTEMS

AAV Vector Development

Adeno-associated viruses (AAVs) are small, non-pathogenic viruses that have become indispensable tools in preclinical ophthalmology research. Our platform offers comprehensive AAV development services, from design and engineering to production and characterization. We specialize in developing vectors optimized for ocular gene delivery, addressing challenges such as retinal penetration and transduction efficiency.

AAV in Preclinical Ophthalmology Studies
  • + Inherited Retinal Diseases
  • + Age-related Macular Degeneration (AMD)
  • + Diabetic Retinopathy
  • + Glaucoma

AI-Driven Innovation

Our platform integrates cutting-edge artificial intelligence (AI) to revolutionize the AAV vector discovery process. By leveraging AI algorithms, we achieve faster discovery cycles, multi-dimensional optimization, and enhanced vector performance.

  • Faster Discovery Cycles

    Accelerated identification of optimal AAV vectors through AI-powered prediction and optimization.

  • Multi-Dimensional Optimization

    Simultaneous optimization of multiple vector parameters for superior performance.

  • Enhanced Vector Performance

    Improved transduction efficiency, targeted delivery, and reduced immunogenicity through AI-driven design.

Targeted AAV Vector Development Services

  • AAV Vector Development Services

    Our AAV vector development services encompass the entire workflow, from design and engineering to production and characterization. We provide customized solutions for diverse ocular gene therapy applications.

    Learn More
  • rAAV Vector Development Services

    Our recombinant AAV (rAAV) vector development services leverage the latest advancements in vector engineering to provide highly efficient and targeted gene delivery solutions for ocular diseases.

    Learn More

Your Partner in AAV Vector Discovery and Development

We offer customized solutions tailored to your specific needs, from individual service components to comprehensive program management. Contact us today to discuss your project.

Contact Us
For Research Use Only.

Ace Therapeutics is a research service provider specializing in ophthalmology. We are dedicated to providing exceptional research services that support drug development programs for clients worldwide.

Important Links
Contact Us
Copyright © Ace Therapeutics. All Rights Reserved.
Top